Emerging Basal Insulins for Diabetes

Program Goals

The Barrier of Hypoglycemia in Diabetes

Hypoglycemia and Cardiovascular Events

Insulin Glargine U-300

Reductions in Nocturnal Hypoglycemia With U-300

PK/PD Profile Glargine U-300

EDITION I-III (Meta-analysis) Nocturnal Hypoglycemia (Rates)

EDITION I-III (Meta-analysis) Body Weight

EDITION I-III (Meta-analysis) Basal Insulin Doses

Insulin Degludec An Ultra-Long-Acting Basal Insulin Analog

Insulin Degludec Pharmacodynamics at Steady State

Insulin Degludec Duration of Action

Insulin Degludec Low Within-Patient Variability

Insulin Degludec vs Insulin Glargine Hypoglycemia Results

Emerging Intensification Strategy

Peglispro (BIL)*

Key Takeaway Points of Next-Generation Basal Insulin Analogs

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)